NanoGroup S.A. (NNG.WA)

1.3850 +0.0100 (+0.73%) At close: 04:49PM CEST

NanoGroup S.A.

ul. Rakowiecka 36
Warsaw 02-532
Poland
48 604 74 13 03
https://nanogroup.eu

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Przemyslaw Daniel Mazurek	President of the Management Board	38k	N/A	N/A
Mr. Piotr Pietrzak	Vice President of the Management Board	202k	N/A	N/A
Prof. Tomasz Adam Ciach	Founder & Member of the Management Board	150.55k	N/A	N/A
Mr. Adam Aleksandrowicz	Chief Financial Officer	N/A	N/A	1972
Ms. Anna Redwan	Chief Operating Officer	N/A	N/A	N/A
Wioletta Kosnik	Member of the Management Board of NanoVelos SA	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in PLN.

Description

NanoGroup S.A. operates as a biotechnology company in Poland. The company develops and licenses early-stage pre-clinical and IND solutions to international biotech and pharma companies. It also manages a portfolio of companies that manages projects for the need of modern medicine in the field of oncology and transplantology. The company was incorporated in 2016 and is based in Warsaw, Poland.

Corporate Governance

NanoGroup S.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.